急性反復発作の世界市場（～2026年）

• 英文タイトル：Global Acute Repetitive Seizures Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY13569
• 出版社/出版日：QYResearch / 2020年11月30日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は急性反復発作のグローバル市場について調査・分析したレポートです。種類別（USL-261、NRL-1、AZ-002、ジアゼパム直腸ゲル、その他）市場規模、用途別（病院、診療所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別急性反復発作の競争状況、市場シェア
・世界の急性反復発作市場：種類別市場規模 2015年-2020年（USL-261、NRL-1、AZ-002、ジアゼパム直腸ゲル、その他）
・世界の急性反復発作市場：種類別市場規模予測 2021年-2026年（USL-261、NRL-1、AZ-002、ジアゼパム直腸ゲル、その他）
・世界の急性反復発作市場：用途別市場規模 2015年-2020年（病院、診療所）
・世界の急性反復発作市場：用途別市場規模予測 2021年-2026年（病院、診療所）
・北米の急性反復発作市場分析：米国、カナダ
・ヨーロッパの急性反復発作市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの急性反復発作市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の急性反復発作市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの急性反復発作市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：UCB S.A.、Neurelis、Valeant Pharmaceuticals North America LLC.、Alexza Pharmaceuticals、Veriton Pharma
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Based on product, the market is categorized into USL-261, NRL-1, AZ-002, Diastat Rectal Gel {DRG.

Market Analysis and Insights: Global Acute Repetitive Seizures Market
The global Acute Repetitive Seizures market size is projected to reach US$ 245.3 million by 2026, from US$ 174.4 million in 2020, at a CAGR of 38.7%% during 2021-2026.

Global Acute Repetitive Seizures Scope and Market Size
Acute Repetitive Seizures market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Repetitive Seizures market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
UCB S.A.
Neurelis
Valeant Pharmaceuticals North America LLC.
Alexza Pharmaceuticals
Veriton Pharma
…

Market segment by Type, the product can be split into
USL-261
NRL-1
AZ-002
Diastat Rectal Gel
Others
Market segment by Application, split into
Hospitals
Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Repetitive Seizures Revenue
1.4 Market by Type
1.4.1 Global Acute Repetitive Seizures Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 USL-261
1.4.3 NRL-1
1.4.4 AZ-002
1.4.5 Diastat Rectal Gel
1.4.6 Others
1.5 Market by Application
1.5.1 Global Acute Repetitive Seizures Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Acute Repetitive Seizures Market Perspective (2015-2026)
2.2 Global Acute Repetitive Seizures Growth Trends by Regions
2.2.1 Acute Repetitive Seizures Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acute Repetitive Seizures Historic Market Share by Regions (2015-2020)
2.2.3 Acute Repetitive Seizures Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Acute Repetitive Seizures Market Growth Strategy
2.3.6 Primary Interviews with Key Acute Repetitive Seizures Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Acute Repetitive Seizures Players by Market Size
3.1.1 Global Top Acute Repetitive Seizures Players by Revenue (2015-2020)
3.1.2 Global Acute Repetitive Seizures Revenue Market Share by Players (2015-2020)
3.1.3 Global Acute Repetitive Seizures Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Repetitive Seizures Market Concentration Ratio
3.2.1 Global Acute Repetitive Seizures Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acute Repetitive Seizures Revenue in 2019
3.3 Acute Repetitive Seizures Key Players Head office and Area Served
3.4 Key Players Acute Repetitive Seizures Product Solution and Service
3.5 Date of Enter into Acute Repetitive Seizures Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Acute Repetitive Seizures Historic Market Size by Type (2015-2020)
4.2 Global Acute Repetitive Seizures Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Acute Repetitive Seizures Market Size by Application (2015-2020)
5.2 Global Acute Repetitive Seizures Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Acute Repetitive Seizures Market Size (2015-2020)
6.2 Acute Repetitive Seizures Key Players in North America (2019-2020)
6.3 North America Acute Repetitive Seizures Market Size by Type (2015-2020)
6.4 North America Acute Repetitive Seizures Market Size by Application (2015-2020)

7 Europe
7.1 Europe Acute Repetitive Seizures Market Size (2015-2020)
7.2 Acute Repetitive Seizures Key Players in Europe (2019-2020)
7.3 Europe Acute Repetitive Seizures Market Size by Type (2015-2020)
7.4 Europe Acute Repetitive Seizures Market Size by Application (2015-2020)

8 China
8.1 China Acute Repetitive Seizures Market Size (2015-2020)
8.2 Acute Repetitive Seizures Key Players in China (2019-2020)
8.3 China Acute Repetitive Seizures Market Size by Type (2015-2020)
8.4 China Acute Repetitive Seizures Market Size by Application (2015-2020)

9 Japan
9.1 Japan Acute Repetitive Seizures Market Size (2015-2020)
9.2 Acute Repetitive Seizures Key Players in Japan (2019-2020)
9.3 Japan Acute Repetitive Seizures Market Size by Type (2015-2020)
9.4 Japan Acute Repetitive Seizures Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Acute Repetitive Seizures Market Size (2015-2020)
10.2 Acute Repetitive Seizures Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Repetitive Seizures Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Repetitive Seizures Market Size by Application (2015-2020)

11 India
11.1 India Acute Repetitive Seizures Market Size (2015-2020)
11.2 Acute Repetitive Seizures Key Players in India (2019-2020)
11.3 India Acute Repetitive Seizures Market Size by Type (2015-2020)
11.4 India Acute Repetitive Seizures Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Acute Repetitive Seizures Market Size (2015-2020)
12.2 Acute Repetitive Seizures Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Repetitive Seizures Market Size by Type (2015-2020)
12.4 Central & South America Acute Repetitive Seizures Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 UCB S.A.
13.1.1 UCB S.A. Company Details
13.1.2 UCB S.A. Business Overview
13.1.3 UCB S.A. Acute Repetitive Seizures Introduction
13.1.4 UCB S.A. Revenue in Acute Repetitive Seizures Business (2015-2020))
13.1.5 UCB S.A. Recent Development
13.2 Neurelis
13.2.1 Neurelis Company Details
13.2.2 Neurelis Business Overview
13.2.3 Neurelis Acute Repetitive Seizures Introduction
13.2.4 Neurelis Revenue in Acute Repetitive Seizures Business (2015-2020)
13.2.5 Neurelis Recent Development
13.3 Valeant Pharmaceuticals North America LLC.
13.3.1 Valeant Pharmaceuticals North America LLC. Company Details
13.3.2 Valeant Pharmaceuticals North America LLC. Business Overview
13.3.3 Valeant Pharmaceuticals North America LLC. Acute Repetitive Seizures Introduction
13.3.4 Valeant Pharmaceuticals North America LLC. Revenue in Acute Repetitive Seizures Business (2015-2020)
13.3.5 Valeant Pharmaceuticals North America LLC. Recent Development
13.4 Alexza Pharmaceuticals
13.4.1 Alexza Pharmaceuticals Company Details
13.4.2 Alexza Pharmaceuticals Business Overview
13.4.3 Alexza Pharmaceuticals Acute Repetitive Seizures Introduction
13.4.4 Alexza Pharmaceuticals Revenue in Acute Repetitive Seizures Business (2015-2020)
13.4.5 Alexza Pharmaceuticals Recent Development
13.5 Veriton Pharma
13.5.1 Veriton Pharma Company Details
13.5.2 Veriton Pharma Business Overview
13.5.3 Veriton Pharma Acute Repetitive Seizures Introduction
13.5.4 Veriton Pharma Revenue in Acute Repetitive Seizures Business (2015-2020)
13.5.5 Veriton Pharma Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Acute Repetitive Seizures Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Repetitive Seizures Revenue
Table 3. Ranking of Global Top Acute Repetitive Seizures Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Repetitive Seizures Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of USL-261
Table 6. Key Players of NRL-1
Table 7. Key Players of AZ-002
Table 8. Key Players of Diastat Rectal Gel
Table 9. Key Players of Others
Table 10. Global Acute Repetitive Seizures Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Acute Repetitive Seizures Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Acute Repetitive Seizures Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Acute Repetitive Seizures Market Share by Regions (2015-2020)
Table 14. Global Acute Repetitive Seizures Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Acute Repetitive Seizures Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Acute Repetitive Seizures Market Growth Strategy
Table 20. Main Points Interviewed from Key Acute Repetitive Seizures Players
Table 21. Global Acute Repetitive Seizures Revenue by Players (2015-2020) (Million US$)
Table 22. Global Acute Repetitive Seizures Market Share by Players (2015-2020)
Table 23. Global Top Acute Repetitive Seizures Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Repetitive Seizures as of 2019)
Table 24. Global Acute Repetitive Seizures by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Acute Repetitive Seizures Product Solution and Service
Table 27. Date of Enter into Acute Repetitive Seizures Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Acute Repetitive Seizures Market Size by Type (2015-2020) (Million US$)
Table 30. Global Acute Repetitive Seizures Market Size Share by Type (2015-2020)
Table 31. Global Acute Repetitive Seizures Revenue Market Share by Type (2021-2026)
Table 32. Global Acute Repetitive Seizures Market Size Share by Application (2015-2020)
Table 33. Global Acute Repetitive Seizures Market Size by Application (2015-2020) (Million US$)
Table 34. Global Acute Repetitive Seizures Market Size Share by Application (2021-2026)
Table 35. North America Key Players Acute Repetitive Seizures Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Acute Repetitive Seizures Market Share (2019-2020)
Table 37. North America Acute Repetitive Seizures Market Size by Type (2015-2020) (Million US$)
Table 38. North America Acute Repetitive Seizures Market Share by Type (2015-2020)
Table 39. North America Acute Repetitive Seizures Market Size by Application (2015-2020) (Million US$)
Table 40. North America Acute Repetitive Seizures Market Share by Application (2015-2020)
Table 41. Europe Key Players Acute Repetitive Seizures Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Acute Repetitive Seizures Market Share (2019-2020)
Table 43. Europe Acute Repetitive Seizures Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Acute Repetitive Seizures Market Share by Type (2015-2020)
Table 45. Europe Acute Repetitive Seizures Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Acute Repetitive Seizures Market Share by Application (2015-2020)
Table 47. China Key Players Acute Repetitive Seizures Revenue (2019-2020) (Million US$)
Table 48. China Key Players Acute Repetitive Seizures Market Share (2019-2020)
Table 49. China Acute Repetitive Seizures Market Size by Type (2015-2020) (Million US$)
Table 50. China Acute Repetitive Seizures Market Share by Type (2015-2020)
Table 51. China Acute Repetitive Seizures Market Size by Application (2015-2020) (Million US$)
Table 52. China Acute Repetitive Seizures Market Share by Application (2015-2020)
Table 53. Japan Key Players Acute Repetitive Seizures Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Acute Repetitive Seizures Market Share (2019-2020)
Table 55. Japan Acute Repetitive Seizures Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Acute Repetitive Seizures Market Share by Type (2015-2020)
Table 57. Japan Acute Repetitive Seizures Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Acute Repetitive Seizures Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Acute Repetitive Seizures Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Acute Repetitive Seizures Market Share (2019-2020)
Table 61. Southeast Asia Acute Repetitive Seizures Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Acute Repetitive Seizures Market Share by Type (2015-2020)
Table 63. Southeast Asia Acute Repetitive Seizures Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Acute Repetitive Seizures Market Share by Application (2015-2020)
Table 65. India Key Players Acute Repetitive Seizures Revenue (2019-2020) (Million US$)
Table 66. India Key Players Acute Repetitive Seizures Market Share (2019-2020)
Table 67. India Acute Repetitive Seizures Market Size by Type (2015-2020) (Million US$)
Table 68. India Acute Repetitive Seizures Market Share by Type (2015-2020)
Table 69. India Acute Repetitive Seizures Market Size by Application (2015-2020) (Million US$)
Table 70. India Acute Repetitive Seizures Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Acute Repetitive Seizures Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Acute Repetitive Seizures Market Share (2019-2020)
Table 73. Central & South America Acute Repetitive Seizures Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Acute Repetitive Seizures Market Share by Type (2015-2020)
Table 75. Central & South America Acute Repetitive Seizures Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Acute Repetitive Seizures Market Share by Application (2015-2020)
Table 77. UCB S.A. Company Details
Table 78. UCB S.A. Business Overview
Table 79. UCB S.A. Product
Table 80. UCB S.A. Revenue in Acute Repetitive Seizures Business (2015-2020) (Million US$)
Table 81. UCB S.A. Recent Development
Table 82. Neurelis Company Details
Table 83. Neurelis Business Overview
Table 84. Neurelis Product
Table 85. Neurelis Revenue in Acute Repetitive Seizures Business (2015-2020) (Million US$)
Table 86. Neurelis Recent Development
Table 87. Valeant Pharmaceuticals North America LLC. Company Details
Table 88. Valeant Pharmaceuticals North America LLC. Business Overview
Table 89. Valeant Pharmaceuticals North America LLC. Product
Table 90. Valeant Pharmaceuticals North America LLC. Revenue in Acute Repetitive Seizures Business (2015-2020) (Million US$)
Table 91. Valeant Pharmaceuticals North America LLC. Recent Development
Table 92. Alexza Pharmaceuticals Company Details
Table 93. Alexza Pharmaceuticals Business Overview
Table 94. Alexza Pharmaceuticals Product
Table 95. Alexza Pharmaceuticals Revenue in Acute Repetitive Seizures Business (2015-2020) (Million US$)
Table 96. Alexza Pharmaceuticals Recent Development
Table 97. Veriton Pharma Company Details
Table 98. Veriton Pharma Business Overview
Table 99. Veriton Pharma Product
Table 100. Veriton Pharma Revenue in Acute Repetitive Seizures Business (2015-2020) (Million US$)
Table 101. Veriton Pharma Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Repetitive Seizures Market Share by Type: 2020 VS 2026
Figure 2. USL-261 Features
Figure 3. NRL-1 Features
Figure 4. AZ-002 Features
Figure 5. Diastat Rectal Gel Features
Figure 6. Others Features
Figure 7. Global Acute Repetitive Seizures Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Acute Repetitive Seizures Report Years Considered
Figure 11. Global Acute Repetitive Seizures Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Acute Repetitive Seizures Market Share by Regions: 2020 VS 2026
Figure 13. Global Acute Repetitive Seizures Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Acute Repetitive Seizures Market Share by Players in 2019
Figure 16. Global Top Acute Repetitive Seizures Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Repetitive Seizures as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Acute Repetitive Seizures Revenue in 2019
Figure 18. North America Acute Repetitive Seizures Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Acute Repetitive Seizures Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Acute Repetitive Seizures Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Acute Repetitive Seizures Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Acute Repetitive Seizures Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Acute Repetitive Seizures Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Acute Repetitive Seizures Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

急性反復発作薬の世界市場（～2026年）

Global Acute Repetitive Seizures Drugs Market Size, Status and Forecast 2020-2026
MRC2-11QY13568 2020年11月30日 98Pages
当調査資料は急性反復発作薬のグローバル市場について調査・分析したレポートです。種類別（注射、胃腸、その他）市場規模、用途別（病院、研究所、薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台...

強直間代発作の世界市場（～2026年）

Global Tonic-Clonic Seizures Market Size, Status and Forecast 2020-2026
MRC2-11QY04863 2020年11月20日 93Pages
当調査資料は強直間代発作のグローバル市場について調査・分析したレポートです。種類別（バルビツール酸塩、ヒダントイン、フェニルトリアジン、イミノスチルベン、ベンゾジアゼピン、脂肪族カルボン酸、その他）市場規模、用途別（病院、診療所、学術研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロ...

急性腎不全治療薬の世界市場（～2026年）

Global Acute Renal Failure Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY13567 2020年11月30日 99Pages
当調査資料は急性腎不全治療薬のグローバル市場について調査・分析したレポートです。種類別（重炭酸ナトリウム、N-アセチルシステイン、スタチン、その他）市場規模、用途別（病院、診療所、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

急性骨髄性白血病の世界市場（～2026年）

Global Acute Myeloid Leukemia Market Size, Status and Forecast 2020-2026
MRC2-11QY13564 2020年11月30日 93Pages
当調査資料は急性骨髄性白血病のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、幹細胞移植、標的療法、その他）市場規模、用途別（病院、小売ドラッグストア、外来診療センター、腫瘍センター、診療所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

急性心不全（AHF）治療薬の世界市場（～2026年）

Global Acute Heart Failure (AHF) Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY13562 2020年11月30日 93Pages
当調査資料は急性心不全（AHF）治療薬のグローバル市場について調査・分析したレポートです。種類別（B遮断薬、カルシウムチャネル遮断薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他）市場規模、用途別（病院、診療所、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...

急性骨髄性白血病治療薬の世界市場（～2026年）

Global Acute Myeloid Leukemia Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY13565 2020年11月30日 96Pages
当調査資料は急性骨髄性白血病治療薬のグローバル市場について調査・分析したレポートです。種類別（パイプライン薬、化学療法薬、化学療法レジメン）市場規模、用途別（病院、診療所、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

急性感音難聴治療の世界市場（～2026年）

Global Acute Sensorineural Hearing Loss Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13570 2020年11月30日 95Pages
当調査資料は急性感音難聴治療のグローバル市場について調査・分析したレポートです。種類別（全身ステロイド、抗ウイルス薬、血管拡張薬、炭素療法、その他）市場規模、用途別（病院、耳科クリニック、外来クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、...

急性疼痛管理サービスの世界市場（～2026年）

Global Acute Pain Management Services Market Size, Status and Forecast 2020-2026
MRC2-11QY13566 2020年11月30日 90Pages
当調査資料は急性疼痛管理サービスのグローバル市場について調査・分析したレポートです。種類別（がんによる痛み、関節炎痛、神経障害性痛、その他）市場規模、用途別（病院、診療所、家庭用）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国...

急性リンパ芽球性白血病薬の世界市場（～2026年）

Global Acute Lymphoblastic Leukemia Drug Market Insights and Forecast to 2026
MRC2-11QY02087 2020年11月20日 112Pages
当調査資料は急性リンパ芽球性白血病薬のグローバル市場について調査・分析したレポートです。種類別（経口、非経口）市場規模、用途別（病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米...

急性冠症候群治療薬の世界市場（～2026年）

Global Acute Coronary Syndrome Therapeutics Market Insights and Forecast to 2026
MRC2-11QY02086 2020年11月20日 111Pages
当調査資料は急性冠症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（急性冠症候群第I相薬、急性冠症候群第II相薬、急性冠症候群第III相薬）市場規模、用途別（病院、クリニック、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

急性反復発作薬の世界市場（～2026年） Market Analysis and Insights: Global Acute Repetitive Seizures Drugs Market The global Acute Repetitive Seizures Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Acute Repetitive Seizures Drugs Scope and Market Si…
強直間代発作の世界市場（～2026年） Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic–clonic …
急性腎不全治療薬の世界市場（～2026年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
急性脊髄損傷の世界市場（～2026年） Acute spinal cord injury (SCI) is a clinical condition caused due to a painful injury that result in a contusion or bruise to a fractional or complete spinal cord resulting into permanent disability and/or death in adults and children. The treatment of acute spinal cord injury is dependent on few f…
急性冠症候群（ACS）の世界市場（～2026年） Acute coronary syndrome (ACS) is a syndrome (set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, cru…